Briacell Therapeutics Corp (BCTX) Financials

$3.60

$-0.03 (-0.83%)

As on 02-Sep-2026 14:32EDT

Market cap

$32 Mln

Revenue (TTM)

$0 Mln

P/E Ratio

--

P/B Ratio

1.3

Div. Yield

0 %

Annual
Quarterly

Cashflow ($ Mln)	TTM	Jul-25	Jul-24	Jul-23	Jul-22	Jul-21	Jul-20	Jul-19	Jul-18	Jul-17	Jul-16
Cash From Operating Activities	--	-39.07	-32.97	-31.89	-15.87	-9.89
Cash Flow from Investing Activities	--	-10.61	-0.93	--	--	--
Cash from Financing Activities	--	63.04	6.04	5.31	-4.76	82.92
Net Cash Inflow / Outflow	--	--	--	--	-16.23	--

Financials Ratios	TTM	Jul-25	Jul-24	Jul-23	Jul-22	Jul-21	Jul-20	Jul-19	Jul-18	Jul-17	Jul-16
Adjusted EPS ($)	--	--	--	--	--	--
Cash EPS ($)	--	--	--	--	--	--
Adjusted Book Value ($)	--	--	--	--	--	--
Dividend per Share ($)	--	--	--	--	--	--
Cash Flow per Share ($)	--	--	--	--	--	--
Free Cash Flow per Share ($)	--	--	--	--	--	--

Profitability Ratios	TTM	Jul-25	Jul-24	Jul-23	Jul-22	Jul-21	Jul-20	Jul-19	Jul-18	Jul-17	Jul-16
ROCE (%)	--	-343.03	114.78	-661.16	-143.83	-110.45
ROE (%)	-216.45	-343.03	114.78	-661.16	-143.93	-111.45
ROA (%)	-115.60	-192.49	-21.58	-59.67	-54.14	-47.27
EBIT Margin (%)	-16,965.60	--	--	--	--	--
Net Margin (%)	-16,448.03	--	--	--	--	--
Cash Profit Margin (%)	-0.19	--	--	--	--	--

Growth Ratios	TTM	Jul-25	Jul-24	Jul-23	Jul-22	Jul-21	Jul-20	Jul-19	Jul-18	Jul-17	Jul-16
Revenue Growth (%)	893.96	--	--	--	--	--
EBIT Growth (%)	-11.47	-664.83	84.13	9.70	-100.47	-254.86
Net Profit Growth (%)	-34.96	-661.35	82.32	21.23	-99.34	-249.34
EPS Growth (%)	--	--	--	--	--	--
Book Value Growth (%)	--	--	--	--	--	--

Valuation Ratios	TTM	Jul-25	Jul-24	Jul-23	Jul-22	Jul-21	Jul-20	Jul-19	Jul-18	Jul-17	Jul-16
Price / Earnings	--	--	--	--	--	--
Price / Book Value	1.34	--	--	--	--	--
Dividend Yield (%)	--	--	--	--	--	--
EV/EBITDA	-1.38	0.65	0.25	0.91	1.53	4.17
Close Price ($)	4.18	7.46	112.88	993.89	965.66	754.70
High Price ($)	44.99	294.00	1,127.60	1,243.47	1,852.58	1,337.06
Low Price ($)	3.60	6.90	90.18	628.43	603.17	418.19
Market Cap ($ Cr)	32.45	--	--	--	--	--

Solvency Ratios	TTM	Jul-25	Jul-24	Jul-23	Jul-22	Jul-21	Jul-20	Jul-19	Jul-18	Jul-17	Jul-16
Debt to Equity	--	--	--	--	--	0.00
Short term debt to equity ratio	--	--	--	--	--	--
Current Ratio	7.07	5.01	0.49	14.96	45.00	103.81
Quick Ratio	7.07	--	0.62	12.60	45.02	103.06
Interest Coverage	-1,262.05	-735.69	--	--	-27,667.98	-171.32

Operating Efficiency Ratios	TTM	Jul-25	Jul-24	Jul-23	Jul-22	Jul-21	Jul-20	Jul-19	Jul-18	Jul-17	Jul-16
Debtors to sales (%)	1,148.82	--	--	--	--	--
Asset Turnover	0.01	--	--	--	--	--
Receivable days	--	--	--	--	--	--
Inventory Days	--	-3,382.57	9,513.41	66,409.29	5,936.63	8,384.12
Payable days	--	17,868.11	25,335.68	24,636.86	10,395.34	3,186.44
Cash Conversion Cycle	--	--	--	--	--	--

*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.